Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients

By Versiani Marcio  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 3, 2000-09 ,pp. : 201-208

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Onset of action under antidepressant treatment

By Stassen H.   Angst J.   Delini-Stula A.  

European Psychiatry, Vol. 12, Iss. 4, 1997-01 ,pp. : 163-165

Elsevier

Access to resources Recommend Favorite

Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors

By Joseph Megan F   Youngstrom Eric A   Soares Jair C  

Future Neurology, Vol. 4, Iss. 1, 2009-01 ,pp. : 87-102

Future Medicine

Access to resources Recommend Favorite

Factors affecting preference for herbal products among patients taking selective serotonin re-uptake inhibitors

By Rascoe Terry G.   Forjuoh Samuel N.   Couchman Glen R.   Reis Michael D.   Kirkpatrick Michael O.   van Walsum Kimberly L.  

Primary Care Psychiatry, Vol. 9, Iss. 3, 2004-09 ,pp. : 77-82

Informa Healthcare

Access to resources Recommend Favorite

Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain

By Linnér L.   Wiker C.   Arborelius L.   Schalling M.   Svensson T. H.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 127-139

Springer Publishing Company

Access to resources Recommend Favorite